2012 Translational Research Excellence (TRX12) and The Bioenergy and Bioproducts Symposium (TBBS) in Brisbane on 26 Oct 2012

August 21st, 2012 | Categories: 2012 | Tags:

TRX12

Building on the success of TRX09 and TRX10, TRX12 aims to set new standards for the region in stimulating trans-disciplinary collaborations across all areas of human disease research, drug and diagnostic discovery and development, IT and bioinformatics.

 

Managers and scientists in medical research institutes, universities and bio-pharmaceutical companies have witnessed an explosive development in the application of powerful computing, laboratory automation, and molecular sciences. The world over, the convergence of these disciplines brings about a fundamental shift in the way medical research, drug research and, ultimately, patient care is undertaken. This shift also impacts academia, industry and governments.

 

Pharmacogenomics, toxicogenomics, visualisation of disease mechanisms and many other innovative disciplines and technologies all produce an incredible amount of data that then needs to be managed, analysed and interpreted in a relevant biological and medical context which is made possible by bioinformatics – the application of information technology, statistics and mathematics to biological and medical problems involving large volumes of data with complex inter-relationships.

 

In order to create an international awareness focussed on the Asia-Pacific Region’s current translational biomedical research, IT and bioinformatics capabilities, TRX12 brings together these diverse yet related disciplines and stakeholders in the relaxed subtropical surroundings of Brisbane in Queensland and provides a platform where delegates can share issues and best practices related to translational research, policy-making, enabling technologies and bioinformatics.

 

TRX12 will bring together key stakeholders from pharma, biotech, the R&D community and government, to discuss how to develop and find new partnerships and winning business models that deliver research with consequences. TRX12 will also be run in conjunction with the inaugural Bioenergy and Bioproducts Symposium which will engage high-level leaders from the national and international Bioenergy and Bioproducts industry and research community to explore the enormous opportunities this area provides.

 

TBBS

Bioenergy and Bioproducts offer enormous potential to companies, investors, researchers, and policy makers to transition bioinventions from research to market.

 

This Symposium will provide an excellent overview of the Bioenergy and Bioproducts markets, latest trends, products and technological advances. It will investigate aspects of the Bioeconomy, from the different products being developed, issues in supply and demand, sustainability, feedstock diversity and opportunities, the regulatory environment both nationally and globally.

 

Decades of life-sciences research and the development of increasingly powerful tools for obtaining and using biological data have brought us closer to the threshold of a previously unimaginable future and we believe that strong partnerships are vital to the success of any emerging industry, where the private sector with the innovation and capital – and the public sector with consistent policy support, can work together to achieve what was once not possible.

 

Energy independence, food security better health outcomes, environmental processes and public concerns – these are all issues that need to be kept in balance to ensure that the bioeconomy is an integral part of our future wellbeing and prosperity.

 

Creating a bioeconomy isn’t just a challenge to meet, it’s an opportunity to seize and an opportunity that will create new businesses, new industries, and millions of new jobs.

 

you can visit the website www.trx12.com.au for more information.

|

Referrer Plugin made by Electric Guitars.